CRISPR Edited iPS Cell Lines by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada

CRISPR/CAS9 Gene Editing of Human Induced Pluripotent Stem Cells (iPSCs)  


CRISPR Edited iPS Cell Lines by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada product image
CRISPR Edited iPS Cell Lines
Buy Now

Place your order directly with the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Induced pluripotent stem cells (iPSCs), have the capacity to give rise to differentiated progeny arising from of all germ layers of the body including: ectoderm, endoderm, and mesoderm. The ability to expand patient derived human iPSCs in vitro and subject them to cell-type specific differentiation protocols is the basis for generating “disease-in-a-dish” cellular models for basic stem cell research and drug-discovery applications.